Recruiting studies: Staphylococcus Aureus Endocarditis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia
Phase 4 · 1 location(s) · Todd C. Lee MD MPH FIDSA · NCT06650488 Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Phase 2 · 6 location(s) · Todd C. Lee MD MPH FIDSA · NCT04886284 Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
Phase 4 · 18 location(s) · Todd C. Lee MD MPH FIDSA · NCT06637332 Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve Endocarditi
Phase 3 · 31 location(s) · Nantes University Hospital · NCT07345325 Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
Phase 4 · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06650501 Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06457386 Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus
Phase 3 · 1 location(s) · Todd C. Lee MD MPH FIDSA · NCT07253688

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.